Magic Touch SCB

Sirolimus Coated Balloon Catheter

Technical Specification

Drug / Exipient

Drug

Sirolimus

Drug Dose

1.27 μg/mm2

Drug Carrier

Phospholipid

Balloon

Balloon Material

Polyamide

Cathether Design

RX/Monorail

No. of folds

3**

Compliance

Semi-compliant

** 2 folds in 1.50 mm diameter

Delivery System

Shaft Diameter - Proximal

RX/Monorail

Shaft Diameter - Distal

1.95 F

Usable Catheter Length

2.67 F

Tip Profile

0.016”

Nominal Pressure

8 bar

Rated Burst Pressure

14 bar*

Guiding Catheter Compatibility

6F

Guidewire Compatibility

0.014” maximum recommended

Crossing profile (varies with size)

0.029”

We highly recommend preparing the vessel bed before treatment with MagicTouch – SCB
*Do Not Exceed RBP

*The above diagram is just an illustration of the product.
Disclaimer: The law restricts these devices to sale by or on the order of a physician. Indications, contradictions, warnings can be found in the product
labelling / IFU supplied with each device. For restricted use only in countries where product is registered with applicable health authorities.

MAGICTOUCH SCB

MagicTouch – SCB is a Sirolimus Drug Coated Balloon catheter for the treatment of the coronary arteries;
intended for treating In-Stent Restenosis, Small Vessels, Bifurcations lesions and De-Novo lesions.

DE-NOVO LESIONS

Concept of treating with leaving Nothing behind in patients with highly susceptible restenosis rate due to inherent disease conditions and comorbid conditions.

BIFURCATION LESIONS

Addresses the issue of metal to artery ratio by allowing one stent technique and less complications in side branch.

IN-STENT RESTENOSIS

Addresses the issue of restenosis by homogenous drug distribution without further increasing metal load in diffuse, focal and edge stenosis.

SMALL VESSELS

Helps in treating challenging anatomies in small diameter without loosing lumen diameter.

UNIQUE COATING TECHNOLOGY

MagicTouch – SCB is developed with Nanolute Technology which possesses unique circumferential coating technology that facilitates homogeneous drug distribution to target lesions.

COATING
Circumferential Coating is

performed under Low Pressure inflation
leading to 100% surface area coating

REFOLDING
۳ Folds

INFLATION
Homogeneous Drug Delivery

due to Circumferential Coating

NANOLUTE TECHNOLOGY

PHARMACOKINETIC STUDY

In ISR Lesion*

SIROLIMUS DISTRIBUTION STUDY

DTF labelled Sirolimus was used to assess the drug distribution following DCB treatment*

A: Adventitia; EEL: External Elastic Lamina; IEL: Internal Elastic Lamina; L: Lumen; M: Media *EuroIntervention. 2013 May 20;9(1): 148-56

keyboard_arrow_up